List of Mersana Therapeutics patents

Patents where

Current Assignee

Name

Mersana Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11135307 Peptide-containing linkers for antibody-drug conjugates	Patent 11135307 was granted and assigned to Mersana Therapeutics on October, 2021 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	11135307	October 5, 2021
‌ US Patent 8349308 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof	Patent 8349308 was granted and assigned to Mersana Therapeutics on January, 2013 by the United States Patent and Trademark Office.		Mersana Therapeutics	United States Patent and Trademark Office	8349308	January 8, 2013
‌ US Patent 11638760 Pyrrolobenzodiazepine antibody conjugates	Patent 11638760 was granted and assigned to Mersana Therapeutics on May, 2023 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	11638760	May 2, 2023
‌ US Patent 11407825 NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof		Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	11407825	August 9, 2022
‌ US Patent 11596694 Compositions and methods for predicting response to NaPi2b-targeted therapy	Patent 11596694 was granted and assigned to Mersana Therapeutics on March, 2023 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	11596694	March 7, 2023
‌ US Patent 11518812 Monoclonal antibodies against HER2 epitope and methods of use thereof	Patent 11518812 was granted and assigned to Mersana Therapeutics on December, 2022 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	11518812	December 6, 2022
‌ US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof	Patent 10947317 was granted and assigned to Mersana Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	10947317	March 16, 2021
‌ US Patent 10143695 Pyrrolobenzodiazepines and conjugates thereof	Patent 10143695 was granted and assigned to Mersana Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	10143695	December 4, 2018
‌ US Patent 9254339 Protein-polymer-drug conjugates	Patent 9254339 was granted and assigned to Mersana Therapeutics on February, 2016 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9254339	February 9, 2016
‌ US Patent 10526294 Pyrrolobenzodiazepines and conjugates thereof	Patent 10526294 was granted and assigned to Mersana Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	10526294	January 7, 2020
‌ US Patent 9738720 Monoclonal antibodies against HER2 epitope and methods of use thereof	Patent 9738720 was granted and assigned to Mersana Therapeutics on August, 2017 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9738720	August 22, 2017
‌ US Patent 10660901 Pyrrolobenzodiazepines and conjugates thereof	Patent 10660901 was granted and assigned to Mersana Therapeutics on May, 2020 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	10660901	May 26, 2020
‌ US Patent 9555112 Monoclonal antibodies against HER2 epitope and methods of use thereof	Patent 9555112 was granted and assigned to Mersana Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9555112	January 31, 2017
‌ US Patent 8808679 Auristatin compounds and conjugates thereof	Patent 8808679 was granted and assigned to Mersana Therapeutics on August, 2014 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	8808679	August 19, 2014
‌ US Patent 9144615 Protein-polymer-drug conjugates	Patent 9144615 was granted and assigned to Mersana Therapeutics on September, 2015 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9144615	September 29, 2015
‌ US Patent 8821850 Protein-polymer-drug conjugates	Patent 8821850 was granted and assigned to Mersana Therapeutics on September, 2014 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	8821850	September 2, 2014
‌ US Patent 8815226 Protein-polymer-drug conjugates	Patent 8815226 was granted and assigned to Mersana Therapeutics on August, 2014 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	8815226	August 26, 2014
‌ US Patent 9849191 Protein-polymer-drug conjugates	Patent 9849191 was granted and assigned to Mersana Therapeutics on December, 2017 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9849191	December 26, 2017
‌ US Patent 9808528 Protein-polymer-drug conjugates and methods of using same	Patent 9808528 was granted and assigned to Mersana Therapeutics on November, 2017 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9808528	November 7, 2017
‌ US Patent 8399512 Biocompatible biodegradable fumagillin analog conjugates	Patent 8399512 was granted and assigned to Mersana Therapeutics on March, 2013 by the United States Patent and Trademark Office.		Mersana Therapeutics	United States Patent and Trademark Office	8399512	March 19, 2013
‌ US Patent 9770519 Protein-polymer-drug conjugates	Patent 9770519 was granted and assigned to Mersana Therapeutics on September, 2017 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9770519	September 26, 2017
‌ US Patent 9943609 Protein-polymer-drug conjugates	Patent 9943609 was granted and assigned to Mersana Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9943609	April 17, 2018
‌ US Patent 9872918 Hydroxyl-polymer-drug-protein conjugates	Patent 9872918 was granted and assigned to Mersana Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	9872918	January 23, 2018
‌ US Patent 8491880 Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates	Patent 8491880 was granted and assigned to Mersana Therapeutics on July, 2013 by the United States Patent and Trademark Office.		Mersana Therapeutics	United States Patent and Trademark Office	8491880	July 23, 2013
‌ US Patent 10603386 Protein-polymer-drug conjugates		Mersana Therapeutics	Mersana Therapeutics	United States Patent and Trademark Office	10603386	March 31, 2020

Results per page:

33 results

0 selected

33 results

0 selected